---

$1.74

-0.1250 ( -6.72% ) 294.5K

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. The company derives revenues from collaboration and licensing agreements.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-04-08	Sale	-200000.00	Mack Gene
2024-04-01	Buy	30000.00	Riley Jeffrey Scott
2024-03-28	Sale	-18750.00	Alder Matthias
2024-03-25	Sale	-50000.00	Fuggetta Gianluca
2024-03-25	Sale	-370000.00	Alder Matthias
2023-12-22	Sale	-637.00	Alder Matthias
2023-12-14	Sale	-1820.00	Alder Matthias
2023-10-03	Sale	-825.00	Alder Matthias
2023-09-22	Sale	-54900.00	RICHMAN ERIC I
2023-09-22	Sale	-2550.00	Alder Matthias